These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Oral enoximone therapy as a therapeutic bridging before heart transplantation].
    Author: Zeplin HE, Stegmann T, Fell JJ, Dressler HT, Dieterich HA.
    Journal: Z Kardiol; 1990 Nov; 79(11):753-7. PubMed ID: 2148996.
    Abstract:
    A 58-year-old male patient with end-stage cardiomyopathy suffered from cardiac decompensation under parenteral catecholamine medication. Oral therapy with 450 mg Enoximone daily achieved recovery after 4 weeks, so that an orthotopic cardiac transplantation could be performed. The postoperative outcome was uneventful. Selective phosphodiesterase-inhibitors help to fill a therapeutic gap in the management of catecholamine-refractory heart failure.
    [Abstract] [Full Text] [Related] [New Search]